Thus, our work defines C1orf35 as a dual-function oncoprotein that promotes CRC progression by coordinately enhancing tumor-intrinsic growth via the c-Myc/PYCR2 axis and fostering an immune-suppressive niche. Here, MYC is linked to colorectal carcinoma.